Elinest

Product manufactured by Northstar Rx Llc

Application Nr Approved Date Route Status External Links
ANDA091105 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Elinest™ (norgestrel And Ethinyl Estradiol Tablets Usp, 0.3 Mg/0.03 Mg) Is Indicated For The Prevention Of Pregnancy In Women Who Elect To Use This Product As A Method Of Contraception. Oral Contraceptives Are Highly Effective. Table I Lists The Typical Accidental Pregnancy Rates For Users Of Combination Oral Contraceptives And Other Methods Of Contraception. 1 The Efficacy Of These Contraceptive Methods, Except Sterilization, Depends Upon The Reliability With Which They Are Used. Correct And Consistent Use Of Methods Can Result In Lower Failure Rates. Table I : Percentage Of Women Experiencing An Unintended Pregnancy During The First Year Of A Contraceptive Method Method Perfect Use Average Use Levonorgestrel Implants 0.05 0.05 Male Sterilization 0.10 0.15 Female Sterilization 0.50 0.50 Depo-Provera ® (injectable Progestogen) 0.30 0.30 Oral Contraceptive 5 Combined 0.10 Na Progestin Only 0.50 Na Iud Progesterone 1.50 2.00 Copper T 380a 0.60 0.80 Condom (male) Without Spermicide 3 14 (female) Without Spermicide 5 21 Cervical Cap Never Given Birth 9 20 Given Birth 26 40 Vaginal Sponge Never Given Birth 9 20 Given Birth 20 40 Diaphragm With Spermicidal Cream Or Jelly 6 20 Spermicides Alone (foam, Creams, Jellies, And Vaginal Suppositories) 6 26 Periodic Abstinence (all Methods) 1-9* 25 Withdrawal 4 19 No Contraception (planned Pregnancy) 85 85 Na- Not Available *depending On Method (calendar, Ovulation Symptothermal, Post-Ovulation) Adapted From Hatcher Ra Et Al, Contraceptive Technology : 17 T H Revised Edition . Ny, Ny: Ardent Medi, Inc., 1998

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Norgestrel And Ethinyl Estradiol

Comments